// App-Quantinova.ai

: Viral Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: Benefits and Risks for Disease Relapse

Researchers

Presenter

  • Sandrine Loron

Principal Investigators

  • Mohamad Sobh

  • Fiorenza Barraco

  • Xavier Thomas

  • Sophie Ducastelle

  • Myriam Renault

  • Florence Ader

  • Emilie Frobert

  • Franck-Emmanuel Nicolini

  • Hlne Labussire

  • Mauricette Michallet

Medical Centers

  • Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Onco-dermatology unit, Centre Leon Berard, Lyon, France

  • Infectious Diseases, Hospices Civils De Lyon, Lyon,

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Myeloid neoplasms

  • Chronic Lymphocytic Leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Lymphomas

  • Graft-versus-host disease

Biomarkers

  • Soluble Complement 5b-9

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved